英文名稱 |
中文名稱 |
CAS號(hào) |
操作 |
Golvatinib |
|
928037-13-2 |
詳細(xì)
|
Rotigotine |
|
99755-59-6 |
詳細(xì)
|
(2S,4R)-1-[(2S)-2-(tert-butoxycarbonylamino)-3,3-dimethyl-butanoyl]-4-hydroxy-pyrrolidine-2-carboxylic acid |
|
630421-46-4 |
詳細(xì)
|
DOTA-NOC |
|
619300-53-7 |
詳細(xì)
|
CB-839 |
|
1439399-58-2 |
詳細(xì)
|
JNJ-42847922 |
|
1293281-49-8 |
詳細(xì)
|
BMS-986142 |
|
1643368-58-4 |
詳細(xì)
|
Zasocitinib |
|
2272904-53-5 |
詳細(xì)
|
ERK5-IN-1 |
|
1435488-37-1 |
詳細(xì)
|
NSC 98700 |
|
4097-22-7 |
詳細(xì)
|
JNJ-42165279 |
|
1346528-50-4 |
詳細(xì)
|
AC-480 |
|
714971-09-2 |
詳細(xì)
|
6-[(1-acetyl-4-piperidyl)amino]-N-[(2S)-3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydroxy-propyl]pyrimidine-4-carboxamide |
|
1616392-22-3 |
詳細(xì)
|
AZD-1656 Racemate |
|
2265194-11-2 |
詳細(xì)
|
N-[5-(difluoromethoxy)-1H-pyrazol-3-yl]-1-(tetrahydropyran-4-ylmethyl)pyrazolo[3,4-b]pyrazin-6-amine |
|
2888704-84-3 |
詳細(xì)
|
RAS-IN-2 |
|
2765081-21-6 |
詳細(xì)
|
XMU-MP-1 |
|
2061980-01-4 |
詳細(xì)
|
ISRIB |
|
548470-11-7 |
詳細(xì)
|
Boceprevir |
|
394730-60-0 |
詳細(xì)
|
Omeprazole |
|
73590-58-6 |
詳細(xì)
|
Temsavir |
|
701213-36-7 |
詳細(xì)
|
2-[(2S)-1-azabicyclo[2.2.2]octan-2-yl]-6-(3-methyl-1H-pyrazol-4-yl)-1H,4H-thieno[3,2-d]pyrimidin-4-one |
|
1330782-76-7 |
詳細(xì)
|
GSK-356278 |
|
720704-34-7 |
詳細(xì)
|
Ivacaftor |
|
873054-44-5 |
詳細(xì)
|
6-fluoro-3-(7-{[2-(trimethylsilyl)ethoxy]methyl}-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-indole |
|
1802154-20-6 |
詳細(xì)
|
Lenvatinib |
|
417716-92-8 |
詳細(xì)
|
CLP 290 |
|
1181083-81-7 |
詳細(xì)
|
N-[4-[chloro(difluoro)methoxy]phenyl]-6-[(3S)-3-hydroxypyrrolidin-1-yl]-5-(1H-pyrazol-3-yl)pyridine-3-carboxamide |
|
1492952-73-4 |
詳細(xì)
|
GW-2580 |
|
870483-87-7 |
詳細(xì)
|
SB-431542 |
|
301836-41-9 |
詳細(xì)
|
Telotristat ethyl |
|
1033805-22-9 |
詳細(xì)
|
Lifitegrast |
|
1025967-78-5 |
詳細(xì)
|
NSC 33942 |
|
106-37-6 |
詳細(xì)
|
GS 5734 |
|
1809249-37-3 |
詳細(xì)
|
NSC 60534 |
|
3041-16-5 |
詳細(xì)
|
Bempedoic acid |
|
738606-46-7 |
詳細(xì)
|
NSC 39655 |
|
2688-84-8 |
詳細(xì)
|
Riociguat |
|
625115-55-1 |
詳細(xì)
|
PF-06840003 |
|
198474-05-4 |
詳細(xì)
|
4-[[(2S,3R,4R,5S)-3-(3,4-difluoro-2-methoxy-phenyl)-4,5-dimethyl-5-(trifluoromethyl)tetrahydrofuran-2-carbonyl]amino]pyridine-2-carboxamide |
|
2649467-57-0 |
詳細(xì)
|
2-[4-(3-methylpyrazin-2-yl)phenyl]-N-[(1R)-1-[5-(2,2,2-trifluoroethoxy)pyridin-2-yl]ethyl]acetamide |
|
1146395-46-1 |
詳細(xì)
|
flibanserin |
|
167933-07-5 |
詳細(xì)
|
ABBV-744 |
|
2138861-99-9 |
詳細(xì)
|
Clemastine fumarate |
|
14976-57-9 |
詳細(xì)
|
Vortioxetine |
|
508233-74-7 |
詳細(xì)
|
4-hydroxy-2-methoxy-benzaldehyde |
|
18278-34-7 |
詳細(xì)
|
Benztropine mesylate |
|
132-17-2 |
詳細(xì)
|
pimavanserin |
|
706779-91-1 |
詳細(xì)
|
kd-025 |
|
911417-87-3 |
詳細(xì)
|
E-7046 |
|
1369489-71-3 |
詳細(xì)
|
Gemcitabine |
|
95058-81-4 |
詳細(xì)
|
(S)-[(1S,2R,4S,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl](quinolin-4-yl)methanol |
|
118-10-5 |
詳細(xì)
|
Lumateperone |
|
313368-91-1 |
詳細(xì)
|
(2R,3R,4R)-3,4-bis(acetyloxy)-3,4-dihydro-2H-pyran-2-yl]methyl acetate |
|
4098-06-0 |
詳細(xì)
|
Enasidenib |
|
1446502-11-9 |
詳細(xì)
|
Ertugliflozin |
|
1210344-57-2 |
詳細(xì)
|
tasimelteon |
|
609799-22-6 |
詳細(xì)
|
2,4,7-trichloro-8-fluoro-pyrido[4,3-d]pyrimidine |
|
2454396-80-4 |
詳細(xì)
|
(S,S)-Hydrobenzoin |
|
2325-10-2 |
詳細(xì)
|
Empagliflozin |
|
864070-44-0 |
詳細(xì)
|
BC-1382 |
|
2197231-02-8 |
詳細(xì)
|
Alectinib |
|
1256580-46-7 |
詳細(xì)
|
SP-13786 |
|
1448440-52-5 |
詳細(xì)
|
(1R)-6-fluoro-7-(2-fluoro-6-hydroxy-phenyl)-1-(2-isopropyl-4-methyl-3-pyridyl)-4-[(2S)-2-methyl-4-prop-2-enoyl-piperazin-1-yl]pyrido[2,3-d]pyrimidin-2-one |
|
2296729-00-3 |
詳細(xì)
|
Lopinavir |
|
192725-17-0 |
詳細(xì)
|
3-[[3-(cyclopropylsulfamoyl)-7-(2,4-dimethoxypyrimidin-5-yl)-4-quinolyl]amino]-5-(3,5-difluorophenoxy)benzoic acid |
|
1445879-21-9 |
詳細(xì)
|
Tadalafil |
|
171596-29-5 |
詳細(xì)
|
(2S,3S)-2,3-bis(benzoyloxy)butanedioic acid; (3R)-3-cyclopentyl-3-[4-(7-{[2-(trimethylsilyl)ethoxy]methyl}-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile |
|
1236033-04-7 |
詳細(xì)
|
BAY-41-8543 |
|
256498-66-5 |
詳細(xì)
|
(-)-Epicatechin |
|
490-46-0 |
詳細(xì)
|
PF-06650833 |
|
1817626-54-2 |
詳細(xì)
|
N-[(2-methyl-4-{2-[(1-methyl-1H-pyrazol-4-yl)amino]pyrimidin-4-yl}phenyl)methyl]-3-(propan-2-yloxy)azetidine-1-carboxamide |
|
1798787-27-5 |
詳細(xì)
|
Rociletinib |
|
1374640-70-6 |
詳細(xì)
|
Dapagliflozin |
|
461432-26-8 |
詳細(xì)
|
Ponatinib |
|
943319-70-8 |
詳細(xì)
|
1-[6-[[(1S,3S)-3-aminocyclopentyl]amino]-3-pyridyl]pyridin-2-one dihydrochloride |
|
1080028-80-3 |
詳細(xì)
|
Tamoxifen |
|
10540-29-1 |
詳細(xì)
|
Tetrabenazine |
|
58-46-8 |
詳細(xì)
|
PD-126055 free acid |
|
1316755-16-4 |
詳細(xì)
|
6-amino-4-{[3-chloro-4-(pyridin-2-ylmethoxy)phenyl]amino}-7-ethoxyquinoline-3-carbonitrile |
|
848139-78-6 |
詳細(xì)
|
sotagliflozin |
|
1018899-04-1 |
詳細(xì)
|
Virgaureagenin B |
|
508-02-1 |
詳細(xì)
|
MTS |
|
31469-15-5 |
詳細(xì)
|
N-[2-[(3S,4R)-3-fluoro-4-methoxy-1-piperidyl]pyrimidin-4-yl]-5-isopropyl-8-[(2R,3S)-2-methyl-3-(methylsulfonylmethyl)azetidin-1-yl]isoquinolin-3-amine |
|
2660250-10-0 |
詳細(xì)
|
(Z)-4-amino-N-(3-bromo-4-fluorophenyl)-N'-hydroxy-1,2,5-oxadiazole-3-carboximidamide |
|
914638-30-5 |
詳細(xì)
|
AP26113 |
|
1197958-12-5 |
詳細(xì)
|
Cobimetinib |
|
934660-93-2 |
詳細(xì)
|
Canagliflozin |
|
842133-18-0 |
詳細(xì)
|
Ibrutinib |
|
936563-96-1 |
詳細(xì)
|
Reldesemtiv |
|
1345410-31-2 |
詳細(xì)
|
tert-butyl 2-[(5-fluoro-2-pyridyl)oxymethyl]-8-azabicyclo[3.2.1]octane-8-carboxylate |
|
2007919-75-5 |
詳細(xì)
|
PF-06882961 |
|
2230198-02-2 |
詳細(xì)
|
AQW-051 |
|
669770-29-0 |
詳細(xì)
|
Siponimod |
|
1230487-00-9 |
詳細(xì)
|
PF-04447943 |
|
1082744-20-4 |
詳細(xì)
|
BLU-9931 |
|
1538604-68-0 |
詳細(xì)
|
methyl (4R)-4-[(7R,8S,9S,10R,13R,14S,17R)-7-(methoxymethoxy)-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]pentanoate |
|
610313-90-1 |
詳細(xì)
|
Avanafil |
|
330784-47-9 |
詳細(xì)
|
(4R)-4-[(3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid |
|
81-25-4 |
詳細(xì)
|
erlotinib |
|
183321-74-6 |
詳細(xì)
|